HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact on Short-Term Complications of Early Oral Feeding in Patients with Esophageal Cancer After Esophagectomy.

Abstract
To evaluate early oral feeding (EOF) in short-term outcomes of patients with esophageal cancer after esophagectomy. 179 patients with esophageal cancer who underwent esophagectomy between January 2016 and February 2018 were enrolled for this study. 87 patients with EOF without nasogastric tube or nasogastric tube was removed within 24 h, were selected as the experimental group, whereas 92 patients who received nasojejunal tube feeding were set as the control group. All laboratory testing, clinical features, and hospitalization expenses were compared between the two groups. No statistical significance was observed between the two groups in hemoglobin, albumin, and prealbumin levels after esophagectomy. Notably, there was no significant difference in the incidence of severe pneumonia and anastomotic leakage between the two groups. Admittance period, postoperative defecation time, and medical expenses were significantly decreased among patients with EOF (P < 0.001). Multivariate Cox multiple-factor regression analysis revealed that there was no correlation between EOF and the risk of anastomotic leakage. EOF might not be a risk factor for increasing the incidence of severe pneumonia and anastomotic leakage in patients with esophageal cancer after esophagectomy, and it could reduce the hospitalization period as well as control medical expenses.
AuthorsYi Li, Zhenjun Liu, Guangyuan Liu, Qiang Fang, Lili Zhao, Pei Zhao, Jiuhui Wang, Mu Yang
JournalNutrition and cancer (Nutr Cancer) Vol. 73 Issue 4 Pg. 609-616 ( 2021) ISSN: 1532-7914 [Electronic] United States
PMID32482102 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Anastomotic Leak
  • Enteral Nutrition
  • Esophageal Neoplasms (surgery)
  • Esophagectomy (adverse effects)
  • Humans
  • Postoperative Complications (etiology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: